Healthcare provider profile · identity verified

David Matthew Julian, M.D.

Internal Medicine · RENO, NV · NPI 1770525628

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	855	183
Gabapentin	Gabapentin	632	99
Furosemide	Furosemide	430	94
Eliquis	Apixaban	400	76
Amlodipine Besylate	Amlodipine Besylate	393	89
Levothyroxine Sodium	Levothyroxine Sodium	337	74
Pregabalin	Pregabalin	296	13
Clopidogrel	Clopidogrel Bisulfate	278	44
Trazodone Hcl	Trazodone Hcl	271	36
Potassium Chloride	Potassium Chloride	245	47
Lisinopril	Lisinopril	226	46
Tamsulosin Hcl	Tamsulosin Hcl	226	82
Baclofen	Baclofen	221	19
Levetiracetam	Levetiracetam	205	25
Losartan Potassium	Losartan Potassium	192	67
Carvedilol	Carvedilol	190	41
Alprazolam	Alprazolam	185	suppressed
Digoxin	Digoxin	180	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	154	40
Ropinirole Hcl	Ropinirole Hcl	152	20
Clonazepam	Clonazepam	151	suppressed
Metoprolol Succinate	Metoprolol Succinate	150	39
Metformin Hcl	Metformin Hcl	147	28
Oxycodone Hcl	Oxycodone Hcl	147	13
Spironolactone	Spironolactone	147	23
Tramadol Hcl	Tramadol Hcl	142	15
Sertraline Hcl	Sertraline Hcl	122	25
Lacosamide	Lacosamide	106	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	104	30
Carbamazepine Er	Carbamazepine	102	suppressed
Duloxetine Hcl	Duloxetine Hcl	102	23
Glipizide	Glipizide	101	26
Tizanidine Hcl	Tizanidine Hcl	99	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	94	suppressed
Buspirone Hcl	Buspirone Hcl	83	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	78	suppressed
Allopurinol	Allopurinol	75	17
Celecoxib	Celecoxib	73	17
Klor-Con 10	Potassium Chloride	72	20
Xarelto	Rivaroxaban	70	31
Amiodarone Hcl	Amiodarone Hcl	68	25
Quetiapine Fumarate	Quetiapine Fumarate	68	18
Mirtazapine	Mirtazapine	65	12
Fluoxetine Hcl	Fluoxetine Hcl	63	suppressed
Prednisone	Prednisone	61	13
Sodium Chloride	0.9 % Sodium Chloride	60	17
Hydralazine Hcl	Hydralazine Hcl	59	16
Carbamazepine	Carbamazepine	55	suppressed
Montelukast Sodium	Montelukast Sodium	54	13
Sevelamer Carbonate	Sevelamer Carbonate	54	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	52	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	50	suppressed
Olanzapine	Olanzapine	49	suppressed
Zonisamide	Zonisamide	49	suppressed
Estradiol	Estradiol	48	suppressed
Alendronate Sodium	Alendronate Sodium	46	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	46	17
Aripiprazole	Aripiprazole	46	suppressed
Latanoprost	Latanoprost	45	15
Ondansetron Hcl	Ondansetron Hcl	45	16
Paroxetine Hcl	Paroxetine Hcl	44	suppressed
Lovastatin	Lovastatin	43	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	43	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	42	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	41	suppressed
Scopolamine	Scopolamine	41	suppressed
Propranolol Hcl	Propranolol Hcl	40	suppressed
Propranolol Hcl Er	Propranolol Hcl	40	suppressed
Methocarbamol	Methocarbamol	39	14
Albuterol Sulfate Hfa	Albuterol Sulfate	36	28
Carbidopa-Levodopa	Carbidopa/Levodopa	36	suppressed
Methadone Hcl	Methadone Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	12
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Atenolol	Atenolol	30	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	30	13
Metolazone	Metolazone	30	suppressed
Novolog Flexpen	Insulin Aspart	30	suppressed
Sucralfate	Sucralfate	30	suppressed
Lamotrigine	Lamotrigine	29	suppressed
Finasteride	Finasteride	28	22
Midodrine Hcl	Midodrine Hcl	28	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	15
Clonidine Hcl	Clonidine Hcl	26	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	13
Doxycycline Monohydrate	Doxycycline Monohydrate	25	16
Nystatin	Nystatin	25	17
Jardiance	Empagliflozin	24	12
Tradjenta	Linagliptin	23	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	21	suppressed
Ceftriaxone	Ceftriaxone Sodium	20	suppressed
Dexamethasone	Dexamethasone	19	13
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Topiramate	Topiramate	18	suppressed
Vancomycin Hcl	Vancomycin Hcl	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Zosyn	Piperacillin-Tazo-Dextrose,iso	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Bethanechol Chloride	Bethanechol Chloride	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Risperidone	Risperidone	14	suppressed
Torsemide	Torsemide	13	11
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Clobazam	Clobazam	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Ceftriaxone	Ceftriaxone In Is-Osm Dextrose	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Linezolid	Linezolid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error